Biotechnology Industry Organization: 2012 Bio International Convention

Biotechnology Industry Organization: 2012 Bio International Convention

Speaking Engagement
The BIO International Convention is the largest global event for the biotechnology industry, featuring keynotes and sessions from key policymakers, scientists, CEOs and celebrities. This event will offer attendees networking and partnering opportunities and provide insights and inspiration on the major trends affecting the industry. Attendees will have the opportunity to participate in hundreds of sessions covering biotech trends, policy issues and technological innovations, as well as attend the world's largest biotechnology exhibition.

WilmerHale will present a discussion panel at the Biotechnology Industry Organization's 2012 Convention, offering information on the Biotech Patenting and Tech Transfer track. WilmerHale partners Seth Waxman and Mark Fleming will speak during WilmerHale's Panelist Session taking place on Tuesday, June 19 from 8:30-9:45 a.m. about "Recent Developments in Patentability: Prometheus, Myriad, Classen and the Patentability of Diagnostic Methods." The panel will discuss the implications of these cases for biotech patents and the future of biotech innovation, including personalized medicine.

Read More About the Event

Speakers

You May Be Interested In

International Trade Post-Election Update: What to Expect in the New Administration

January 9, 2025
Webinar

Banking Law Committee Meeting 2025

January 10, 2024
Speaking Engagement

The Federal Trade Commission: Priorities for 2025

January 14, 2025
Webinar
View all Events

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel